ByHeart has announced its acquisition of Cascadia Nutrition to establish a dedicated infant formula packaging facility in Portland, Oregon, enhancing its production capabilities and addressing market demands.

Information on the Target

ByHeart, a pioneering baby nutrition company, has announced its acquisition of Cascadia Nutrition, a well-established FDA-registered packaging and blending facility located in Portland, Oregon. This strategic move marks the establishment of the first dedicated infant formula packaging facility in the U.S. in over two decades, enabling ByHeart to enhance its production capabilities for high-quality infant formula. For the past five years, Cascadia has been effectively packaging infant formula for various international brands, and this acquisition will permit them to transition into serving the U.S. market following completion of FDA registration.

The acquisition aims to strengthen resilience within the U.S. infant formula market by providing ByHeart with complete control and oversight of the entire manufacturing process, from production to packaging. Maintaining operational excellence in adherence to ByHeart's quality standards, the company intends to uphold Cascadia's commitment to creating job opportunities, particularly for individuals facing employment barriers. Essential to the integration will be retaining the facility’s existing workforce and ensuring that the legacy of the Balogh family, who previously owned Cascadia, continues in its mission.

Industry Overview in the U.S.

The infant formula industry in the United States has faced significant challenges in recent years, notably highlighted by severe shortages that have placed immense pressure on manufacturers. The COVID-19 pandemic, coupled with supply chain disruptions, has le